According to a technical note issued by ANVISA, Brazilian market participants seeking to make multiple modifications to their cadastro registrations may now submit all proposed changes to regulators using a single application form. The technical note states that ANVISA will also no longer charge a review fee for modification applications for cadastro devices.
